glycerylphosphorylcholine has been researched along with Non-alcoholic Fatty Liver Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrigo, JM; Chan, AW; Chan, FK; Chan, HL; Chim, AM; Choi, PC; Chu, WC; Shen, J; Wong, GL; Wong, VW; Yeung, DK | 1 |
| Ahn, S; Jeon, MJ; Kim, H; Kim, OH; Lee, C; Lee, Y; Oh, BC; Yu, U | 1 |
| Breitbart, E; Ishai, E; Mendel, I; Shoham, A; Yacov, N | 1 |
3 other study(ies) available for glycerylphosphorylcholine and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study.
Topics: Adult; Case-Control Studies; Ethanolamines; Female; Glycerylphosphorylcholine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Nucleotides; Phosphates; Phosphorus | 2014 |
High resolution in vivo 31P-MRS of the liver: potential advantages in the assessment of non-alcoholic fatty liver disease.
Topics: Animals; Disease Models, Animal; Ethanolamines; Glycerylphosphorylcholine; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; NADP; Non-alcoholic Fatty Liver Disease; Phosphatidylethanolamines; Phosphorus; Phosphorylcholine; Rats; Rats, Sprague-Dawley | 2015 |
Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Blotting, Western; Cell Movement; Cytokines; Dendritic Cells; Diabetes Mellitus, Experimental; Diet, High-Fat; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glycerophosphates; Glycerylphosphorylcholine; Hepatic Stellate Cells; Humans; Inflammation; Kupffer Cells; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Monocytes; Non-alcoholic Fatty Liver Disease; Phospholipids; Pyridinium Compounds; Real-Time Polymerase Chain Reaction; Telmisartan; Toll-Like Receptor 2; Toll-Like Receptor 4; Triglycerides | 2016 |